LAS VEGAS--(BUSINESS WIRE)--March 22, 2006--CardioVascular BioTherapeutics, Inc. (OTCBB:CVBT.OB), announced today it has successfully completed the sale in a private placement of $20,000,000 of senior secured notes together with warrants to purchase 705,882 shares of the Company’s common stock.
